超声内镜引导下胆道引流的不良事件:系统评价与荟萃分析
该系统评价与荟萃分析纳入155项研究共7887例患者,评估超声内镜引导下胆道引流(EUS-BD)的不良事件。EUS-BD临床成功率为95%,总体不良事件发生率为13.7%,主要不良事件和操作相关死亡率均低于1%。
要点
- EUS-BD临床成功率为95%,总体不良事件发生率为13.7%。
- 早期不良事件以胆漏最常见(2.2%),其次为胆管炎(1.0%)。
- 主要不良事件发生率为0.6%,操作相关死亡率为0.1%。
核心结论
- 尽管EUS-BD临床成功率高,但约七分之一病例可能发生不良事件;主要不良事件和死亡率均低于1%,令人安心。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、Embase和Scopus从2005年至2022年9月分析EUS-BD结局的研究,最终纳入155项研究共7887例患者。
主要发现
- EUS-BD汇总临床成功率为95%(95%CI 94.1-95.9),总体不良事件发生率为13.7%(95%CI 12.3-15.0)。
- 早期不良事件中胆漏最常见,汇总发生率为2.2%(95%CI 1.8-2.7),其次为胆管炎1.0%(95%CI 0.8-1.3)。
- 主要不良事件汇总发生率为0.6%(95%CI 0.3-0.9),操作相关死亡率为0.1%(95%CI 0.0-0.4)。
- 支架延迟移位和支架闭塞的汇总发生率分别为1.7%(95%CI 1.1-2.3)和11.0%(95%CI 9.3-12.8)。
- 因支架移位或闭塞而再次干预的汇总事件率为16.2%(95%CI 14.0-18.3;I²=77.5%)。
关键数值与推荐
- EUS-BD总体不良事件发生率13.7%(95%CI 12.3-15.0),主要不良事件0.6%(95%CI 0.3-0.9),操作相关死亡率0.1%(95%CI 0.0-0.4)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Multiple meta-analyses have evaluated the technical and clinical success of EUS-guided biliary drainage (BD), but meta-analyses concerning adverse events (AEs) are limited. The present meta-analysis analyzed AEs associated with various types of EUS-BD. METHODS: A literature search of MEDLINE, Embase, and Scopus was conducted from 2005 to September 2022 for studies analyzing the outcome of EUS-BD. The primary outcomes were incidence of overall AEs, major AEs, procedure-related mortality, and reintervention. The event rates were pooled using a random-effects model. RESULTS: One hundred fifty-five studies (7887 patients) were included in the final analysis. The pooled clinical success rates and incidence of AEs with EUS-BD were 95% (95% confidence interval [CI], 94.1-95.9) and 13.7% (95% CI, 12.3-15.0), respectively. Among early AEs, bile leak was the most common followed by cholangitis with pooled incidences of 2.2% (95% CI, 1.8-2.7) and 1.0% (95% CI, .8-1.3), respectively. The pooled incidences of major AEs and procedure-related mortality with EUS-BD were .6% (95% CI, .3-.9) and .1% (95% CI, .0-.4), respectively. The pooled incidences of delayed migration and stent occlusion were 1.7% (95% CI, 1.1-2.3) and 11.0% (95% CI, 9.3-12.8), respectively. The pooled event rate for reintervention (for stent migration or occlusion) after EUS-BD was 16.2% (95% CI, 14.0-18.3; I2 = 77.5%). CONCLUSIONS: Despite a high clinical success rate, EUS-BD may be associated with AEs in one-seventh of the cases. However, major AEs and mortality incidence remain less than 1%, which is reassuring.
引用
- Giri S, Mohan BP, Jearth V, et al. Adverse events with EUS-guided biliary drainage: a systematic review and meta-analysis. Gastrointest Endosc. 2023. PMID: 37392952. doi:10.1016/j.gie.2023.06.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。